DIANE ORAN: Open Payments
NPI 1326171638 · VACAVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,459 in 17 payments from 5 companies in 2025. Trend: 2023 $1,081 · 2024 $745 · 2025 $1,459
Consulting: $740Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $1,076 |
| Otsuka America Pharmaceutical, Inc. | 5 | $221 |
| Luye Pharma (USA) Ltd. | 1 | $97 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
Products named: COBENFY, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, UZEDY, REXULTI, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
